PARTI Overview We area global biopharmaceutical companydedicated to the discovery,developmentand commercialization of clinically differentiated medicines for children and adults living with rare disorders. We are advancing a robust and diversified pipeline of transformative medicines as part of our mission to provide access to best-in-class treatments for patients with unmet medical needs. Our strategy is toleverageour scientificexpertiseand global commercial infrastructure tooptimizevalue for o...
Q2 FY2026 — expected 2026-08-14
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-19 | 2025-12-31 | 0001104659-26-017575 | EDGAR | 140K words |
| 2025-02-27 | 2024-12-31 | 0001070081-25-000012 | EDGAR | — |
| 2024-02-29 | 2023-12-31 | 0001558370-24-002196 | EDGAR | — |
| 2023-02-21 | 2022-12-31 | 0001070081-23-000011 | EDGAR | — |
| 2022-02-22 | 2021-12-31 | 0001070081-22-000011 | EDGAR | — |
| 2021-02-25 | 2020-12-31 | 0001070081-21-000009 | EDGAR | — |
| 2020-03-02 | 2019-12-31 | 0001070081-20-000064 | EDGAR | — |
| 2019-03-01 | 2018-12-31 | 0001070081-19-000018 | EDGAR | — |
| 2018-03-06 | 2017-12-31 | 0001070081-18-000042 | EDGAR | — |
| 2017-03-16 | 2016-12-31 | 0001070081-17-000062 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-04 | 2025-09-30 | 0001070081-25-000028 | EDGAR | 46K words |
| 2025-08-07 | 2025-06-30 | 0001558370-25-010796 | EDGAR | — |
| 2025-05-06 | 2025-03-31 | 0001070081-25-000019 | EDGAR | — |
| 2024-11-07 | 2024-09-30 | 0001070081-24-000023 | EDGAR | — |
| 2024-08-08 | 2024-06-30 | 0001070081-24-000017 | EDGAR | — |
| 2024-04-25 | 2024-03-31 | 0001558370-24-005782 | EDGAR | — |
| 2023-10-26 | 2023-09-30 | 0001070081-23-000065 | EDGAR | — |
| 2023-08-03 | 2023-06-30 | 0001070081-23-000050 | EDGAR | — |
| 2023-04-27 | 2023-03-31 | 0001070081-23-000028 | EDGAR | — |
| 2022-10-27 | 2022-09-30 | 0001070081-22-000041 | EDGAR | — |
| 2022-08-04 | 2022-06-30 | 0001070081-22-000031 | EDGAR | — |
| 2022-05-03 | 2022-03-31 | 0001070081-22-000017 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-25 | 0001104659-26-034207 | EDGAR | 1K words |
| 2026-02-19 | 0001104659-26-017546 | EDGAR | — |
| 2026-02-12 | 0001104659-26-014414 | EDGAR | — |
| 2026-01-12 | 0001104659-26-002799 | EDGAR | — |
| 2025-12-29 | 0001104659-25-124837 | EDGAR | — |
| 2025-11-04 | 0001070081-25-000026 | EDGAR | — |
| 2025-08-19 | 0001558370-25-011658 | EDGAR | — |
| 2025-08-07 | 0001558370-25-010786 | EDGAR | — |
| 2025-08-07 | 0001558370-25-010770 | EDGAR | — |
| 2025-07-28 | 0001558370-25-009663 | EDGAR | — |
201 total filings indexed. 169 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001070081 |
| Ticker | PTCT |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.ptcbio.com |
| Listed | 2013-06-20 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report